Solventum Corp

SOLV is in a Stage 2 advancing uptrend with clear higher highs and higher lows, but price is extended above rising EMAs and in extreme overbought territory. Medium-term structural bias remains bullish, yet short-term timing is unfavorable. Execution is deferred (Stalk) into pullbacks toward the rising EMAs for optimal entry.

• ↑Q1 organic sales rose 2.1% and EPS grew 11% YoY
• ↑Launching ~20 new products over next two years to boost revenue
• ↓Tariff headwinds of $100–120 million in FY26 weigh on margins